protected the cytoarchitecture of the actin. PKC inhibitors prevented these protective effects. Transfected cells stably overexpressing PKC-␤1 (ϩ3.1-fold) but not N cell monolayers were protected from injury by even lower doses of EGF or OAG. EGF or OAG rapidly activated the over-expressed PKC-␤1. Antisense inhibition of PKC-␤1 expression (Ϫ90%) prevented all measures of EGF protection. Inhibitors of Ca 2ϩ -ATPase prevented EGF protection in N cells as well as protective synergism in transfected cells. EGF protects the assembly of the F-actin cytoskeleton in intestinal monolayers against oxidants in large part through the activation of PKC-␤1. EGF normalizes Ca 2ϩ by enhancing Ca 2ϩ efflux through PKC-␤1. We have identified novel biologic functions, protection of actin and Ca 2ϩ homeostasis, among the classical isoforms of PKC.
A fundamental property of the epithelium of the gastrointestinal (GI) mucosa is the ability to maintain a highly selective permeability barrier (Unno et al., 1996; Menconi et al., 1997; Hollander, 1998; Banan et al., 1999; . We (Banan et al., 1996 (Banan et al., , 1998a (Banan et al., ,b, 1999 (Banan et al., , 2000a (Banan et al., ,b,c, 2001a (Banan et al., ,b,c,d,e, 2002 and others (Unno et al., 1996; Menconi et al., 1997) have shown that the integrity of the intestinal barrier depends on the stability of complex intracellular networks of the cytoskeletal elements. Among these elements, the actin cytoskeleton, especially the apical ring of actin cortex, plays a key role in the maintenance of an intact GI epithelial barrier (Banan et al., 1996 (Banan et al., , 2000c (Banan et al., , 2001a Unno et al., 1996; Menconi et al., 1997) . Actin is the principal protein in the cell cortex localized immediately inside the plasma membrane at areas of cell-to-cell contact and represents a critical structural component. As such it plays a crucial role in maintaining the structure of the cytoplasmic matrix, cell shape, and barrier integrity (permeability).
Intestinal barrier integrity is of clinical and biological importance because this barrier normally restricts the passage of harmful pro-inflammatory and toxic molecules (e.g., bacterial endotoxin, immunoreactive antigens) into the mucosa and systemic circulation (Hollander, 1998; Keshavarzian et al., 1999) . Loss of mucosal barrier integrity, on the other hand, is characteristic of multiple organ system dysfunction, inflammatory bowel disease, necrotizing enterocolitis, ethanol-and nonsteroidal anti-inflammatory drug-induced chemical injury, and a variety of other GI disorders as well as several systemic disorders (e.g., alcoholic liver disease) (Unno et al., 1996; Menconi et al., 1997; Hollander, 1998; Keshavarzian et al., 1999) . Although the pathogenesis of mucosal barrier disruption in these illnesses remains unclear, several studies, including our own, have shown that chronic gut inflammation is associated with high levels of oxidants (e.g., H 2 O 2 ) and that oxidative damage is a key contributor to loss of barrier integrity and injury (Keshavarzian et al., 1992; McKenizie et al., 1996; Kimura et al., 1998; Banan et al., 2000a Banan et al., ,b,c, 2001a . Not surprisingly, damage to the actin cytoskeleton (especially to the cortical ring of Factin) can lead to a leaky, hyperpermeable gut, and this damage has been proposed as a key underlying mechanism for the initiation and perpetuation of these oxidant-induced inflammatory disorders. Thus, characterizing the intracellular signaling mechanisms underlying the protection of Factin is both clinically and biologically important.
In our concerted efforts to enhance our understanding of endogenous protective mechanisms for the cytoskeleton and to provide new insights that might lead to developing more effective treatment regimens for oxidative and inflammatory disorders associated with loss of intestinal barrier integrity, we have been investigating the underlying protective mechanisms used by growth factors to stabilize the cytoskeletal network. Utilizing monolayers of human intestinal (Caco-2) cells exposed to oxidants as a model of cytoskeletal and barrier disruption, we previously showed that growth factors (e.g., EGF or transforming growth factor-␣) protect intestinal barrier integrity in part by stabilizing the assembly of the apical ring of the F-actin cytoskeleton (Banan et al., 2000c (Banan et al., , 2001a . We have also shown that the stability of actin is key in mucosal healing under in vivo (Banan et al., 1996) and in vitro (Banan et al., 2000c (Banan et al., , 2001a conditions. Stability is based on the ability of monomeric G-actin to polymerize and on the stability of F-actin polymers to resist disassembly. Despite the critical importance of the F-and G-actin cytoskeleton in the maintenance of intestinal barrier integrity, the intracellular signaling mechanism through which EGF stabilizes the actin remains elusive.
In previous studies using naive Caco-2 cells, we also showed that Ca 2ϩ is crucial in the maintenance of normal mucosal barrier integrity (Kokoska et al., 1998; Banan et al., 2001b) and that EGF protects the monolayer barrier via normalization of intracellular Ca 2ϩ ([Ca 2ϩ ] i ) levels through enhancement of protein kinase C (PKC) in general (Banan et al., 2001b) . The specific isoform of PKC responsible for this protective effect of EGF on Ca 2ϩ homeostasis remains unknown. Utilizing the first developed stably transfected intestinal (Caco-2) cell lines over-expressing or under-expressing PKC, we recently demonstrated that EGF maintains monolayer barrier permeability, in large part, by increasing activity and membrane association of the ␤1 isoform of PKC (Banan et al., 2001c) .
In view of the aforementioned considerations, we hypothesized that the PKC-␤1 isoform not only is essential to EGFinduced protection of the dynamic assembly of the F-and G-actin cellular pools and the stabilization of the cortical actin ring, but it is key to the normalization of Ca 2ϩ homeostasis. To this end, we utilized pharmacological and targeted molecular interventions employing several novel and stably transfected intestinal cell lines we have recently developed. In several clones the classical isoform PKC-␤1 was reliably over-expressed; in other clones, PKC-␤1 expression was inhibited. Herein, we report novel biologic functions, protection of actin and Ca 2ϩ balance, by the classical ␤1 isoform of PKC.
Materials and Methods
Cell Culture. Caco-2 cells, which were obtained from American Type Culture Collection (Manassas, VA) at passage 15, were chosen because they form monolayers that morphologically resemble small intestinal cells, with defined apical brush borders, junctional complexes, and a highly organized actin network (Gilbert et al., 1991; Meunier et al., 1995; Banan et al., 1998b) . Cells were maintained at 37°C in complete Dulbecco's minimum essential medium in an atmosphere of 5% CO 2 and 100% relative humidity. Naive or stably transfected cells (see below) were split at a ratio of 1:6 upon reaching confluence and set up in either 6-or 24-well plates for experiments or T-75 flasks for propagation. Cells grown for barrier function experiments were split at a ratio of 1:2 and seeded at a density of 200,000 cells/cm 2 into 0.4 M Biocoat collagen I cell culture inserts (0.3-cm 2 growth surface; BD Biosciences-Discovery Labware, Bedford, MA), and experiments were performed at least 7 days post-confluence. The media were changed every 2 days. The utility and characterization of this cell line has been previously reported (Gilbert et al., 1991; Meunier et al., 1995; Banan et al., 1998b) . Plasmid. The sense and antisense plasmids of PKC-␤1 were constructed as we previously described (Cho et al., 1998; Banan et al., 2001c,d) . Expression was controlled by ␤-actin promoter. The antisense PKC-␤1 plasmid (p␤-actin SP72-As-PKC-␤1) was constructed by ligating the 2.3-kb EcoRI fragment of PKC-␤1 cDNA from pJ6-PKC-␤1 (Cho et al., 1998) into the unique EcoRI sites of the p␤-actin SP72 vector. The antisense orientation of the plasmid was confirmed by SamI restriction digestion (Cho et al., 1998) .
Stable Transfection. Cultures of Caco-2 cells grown to 50 to 60% confluence were cotransfected with G-418 (selection) resistance plasmid and expression plasmids encoding either PKC-␤1 or antisense-PKC-␤1 by Lipofectin (Lipofectin reagent; Invitrogen, Carlsbad, CA) as we previously described (Banan et al., 2001c) . Control conditions included vector alone. Briefly, cells were incubated for 16 h at 37°C with the plasmid DNA in serum-free media in the presence of LipofectAMINE (25 l/25-cm 2 flask). Subsequently, the DNA-containing solution was removed and replaced by fresh media containing 10% fetal bovine serum to relieve cells from the shock of exposure to serum-free media. Following transfection, cells were subjected to G-418 selection (0.6 mg/ml) over 4 weeks. Resistant cells were maintained in Dulbecco's minimum essential medium/fetal bovine serum and 0.2 mg/ml G-418 (selection medium). PKC protein expression or lack of it was verified by Western blot analysis of cell lysates (see below). Multiple clones stably over-expressing PKC-␤1 or lacking PKC-␤1 were assessed by immunoblotting, plated on cell culture inserts, allowed to form confluent monolayers, and subsequently used for experiments.
Experimental Design. In the first series of experiments, postconfluent monolayers of naive Caco-2 cells were preincubated with EGF (1 to 10 ng/ml) or isotonic saline for 10 min and then exposed to oxidant (H 2 O 2 , 0.5 mM) or vehicle (saline) for 30 min. As we have previously shown (Banan et al., 2000c (Banan et al., , 2001a , H 2 O 2 at 0.5 mM disrupts actin and barrier integrity; EGF at 10 ng/ml (but not 1 ng/ml) prevents this disruption. These experiments were then repeated using monolayers composed of cells either stably over-expressing or almost completely lacking PKC-␤1. Reagents were applied on the apical side of monolayers unless otherwise indicated.
Since our previous studies (Banan et al., 2000a,c) showed that regardless of whether apical or basolateral exposure of oxidants was used, the results were qualitatively similar; all current studies utilized apical application. In all experiments, actin cytoskeletal stability (ring cytoarchitecture, assembly, disassembly), PKC-␤1 subcellular distribution, and Ca 2ϩ homeostasis ([Ca 2ϩ ] i and Ca 2ϩ efflux) were assessed.
In a second series of experiments, monolayers were preincubated (10 min) with either a PKC activator or a PKC inhibitor and then incubated with EGF prior to exposure to oxidant. PKC activators included 1) a synthetic diacylglycerol (OAG; 0.1, 1, 50, and 100 M) or 2) a phorbol ester (12-O-tetradecanoylphorbol 13-acetate, TPA; 0.1, 1, 30, and 60 nM) or its inactive analog 4␣-phorbol 12,13-didecanoate (4␣-PDD; 20 nM) (Banan et al., 2001b,c) . PKC inhibitors included chelerythrine (1 M) or bisindolylmaleimide V (GF 109203 X; 10 nM) or its inactive analog iGF 109203 X. Controls were treated with vehicle (0.02% ethanol). We confirmed (Banan et al., 2001b) that these doses of PKC inhibitors were not injurious to cells .
In a third series of experiments, cell monolayers that were stably over-expressing PKC-␤1 were preincubated (10 min) with low (nonprotective) or high (protective) doses of the PKC activator OAG (0.01 or 50 M), EGF (1 or 10 ng/ml), or vehicle prior to exposure (30 min) to damaging concentrations of oxidant (H 2 O 2 ; 0.5 mM) or vehicle. Vehicle solution for OAG was 0.02% ethanol.
In a fourth series of experiments, monolayers of antisense transfected cells lacking PKC-␤1 protein were treated with high doses of EGF or OAG and then oxidant. In all experiments, expression levels of PKC-␤1 were determined by immunoblotting. In corollary experiments, we investigated the effects of PKC-␤1 under-or over-expression on the state of actin assembly and disassembly and on the stability of the cytoarchitecture of the apical ring of F-actin. Monomeric and polymerized fractions of actin (the structural protein subunit of actin) were isolated and then analyzed by quantitative immunoblotting (Banan et al., 2000c (Banan et al., , 2001a . Actin integrity was assessed by 1) immunofluorescent labeling and fluorescence microscopy to determine the percentage of cells from monolayers displaying a normal apical ring of actin; 2) detailed analysis of cortical actin ring by high-resolution laser scanning confocal microscopy (LSCM); and 3) quantitative immunoblot analysis of monomeric (G-) and polymerized (F-) actin fractions.
In a fifth and final series of experiments, we investigated the role of PKC-␤1 in growth factor-mediated normalization of Ca 2ϩ homeostasis. Outcomes were both [Ca 2ϩ ] i and Ca 2ϩ efflux. Monolayers of either naive or transfected cells (over-or under-expressing PKC-␤1) were preloaded with the appropriate Ca 2ϩ probe (Fluo-3-AM or 45 Ca 2ϩ ), then preincubated for 10 min with EGF or OAG, and finally exposed to oxidant for 30 min. Where indicated, monolayers were also preincubated with a membrane-bound Ca 2ϩ -ATPase pump inhibitor (either vanadate or quercetine; 10 M, 30 min) prior to the EGF or OAG.
Immunofluorescent Staining and High-Resolution Laser Scanning Confocal Microscopy of Actin. Cells from monolayers were fixed in cytoskeletal stabilization buffer and then post-fixed in 95% ethanol at Ϫ20°C, as we previously described (Banan et al., 2000c (Banan et al., , 2001a . Cells were subsequently processed for incubation with fluorescein isothiocyanate-phalloidin (specific for F-actin; Sigma-Aldrich, St. Louis, MO), 1:40 dilution, for 1 h at 37°C. Slides were washed three times in D-phosphate-buffered saline, once with deionized H 2 O, and subsequently mounted in Aquamount (Fisher Scientific, Fair Lawn, NJ). Following staining, cells were observed with an argon laser ( ϭ 488 nm) using a 63ϫ oil immersion plan-apochromat objective, NA 1.4 (Carl Zeiss GmbH, Jena, Germany). Desired areas of monolayers were processed using the image processing software on a Zeiss Ultra high-resolution LSCM (Carl Zeiss). The apical (cortical) rings of actin, which are known to regulate paracellular permeation through monolayers of Caco-2 cells, were examined in a blinded fashion for their overall morphology and disruption as we previously described (Banan et al., 2000c (Banan et al., , 2001a . At least 1200 cells per group (200 ϫ 6 slides) were examined in four different fields by LSCM, and the percentage of cells displaying normal actin ring was determined. The slides were decoded only after examination was complete.
Actin Fractionation and Quantitative Immunoblotting of F-and G-Actin State of Assembly and/or Disassembly. Polymerized (F-) and monomeric (G-) fractions of actin were isolated as we previously described (Banan et al., 2000c (Banan et al., , 2001a . Cells were gently scraped and pelleted with centrifugation at low speed (700 rpm, 7 min, 4°C) and resuspended in actin stabilization-extraction buffer (0.1 M PIPES, pH 6.9, 30% glycerol, 5% dimethyl sulfoxide, 1 mM MgSO 4 , 10 g/ml anti-protease cocktail, 1 mM EGTA, and 1% Triton X-100) at room temperature for 20 min. Actin fractions were separated following a series of centrifugation and extraction steps. Cell lysates were centrifuged at 105,000g for 45 min at 4°C, and the supernatant containing the soluble monomeric pool of G-actin (or S1) was gently removed. The remaining pellet was then resuspended in 0.3 ml of Ca 2ϩ -containing depolymerization buffer (0.1 M PIPES, pH 6.9, 1 mM MgSO 4 , 10 g/ml anti-protease cocktail, and 10 mM CaCl 2 ) and incubated on ice for 60 min. Subsequently, samples were centrifuged at 48,000g for 15 min at 4°C, and the supernatant (S2-or F-fraction, or cold/Ca 2ϩ -soluble fraction) was removed. To ensure the complete removal of the F-fraction, the remaining pellet was treated with the Ca 2ϩ -containing depolymerization buffer twice more by resuspension and centrifugation. The "actin" was recovered by separately incubating (at 37°C for 30 min) the S1 and S2 fractions with stabilizing agents, phalloidin (1 M) and ATP (0.1 mM), in actin stabilization buffer (0.1 M PIPES, pH 6.9, 30% glycerol, 5% dimethyl sulfoxide, 10 g/ml anti-protease cocktail, 1 mM EGTA, 1 mM MgCl 2 , and 0.1 mM ATP) to promote polymerization of actin. Actin was then recovered by centrifugation and resuspended in the above stabilization buffer. Fractionated S1 and S2 samples were then flash-frozen in liquid N 2 and stored at Ϫ70°C until immunoblotting. For immunoblotting, samples (5 g of protein/lane) were placed in a standard SDS sample buffer, boiled for 5 min, and then subjected to PAGE on 7.5% gels. Procedures for Western blotting were performed as previously described (Banan et al., 2000c (Banan et al., , 2001a . To quantify the relative levels of actin, the optical density of the bands corresponding to immunoradiolabeled actin was measured with a laser densitometer.
Fractionation and Western Immunoblotting of PKC. Differentiated cell monolayers grown in 75-cm 2 flasks were processed for the isolation of the cytosolic, membrane, and cytoskeletal fractions as we previously described (Banan et al., 2001b,c) . Briefly, following treatments, post-confluent monolayers were scraped and ultrasonically homogenized in Tris-HCl buffer (20 mM Tris-HCl, pH 7.5, 0.25 mM sucrose, 2 mM EDTA, 10 mM EGTA, 2 g/ml aprotinin, 2 g/ml pepstatin, 2 g/ml leupeptin, and 2 g/ml phenylmethylsulfonyl fluoride). The homogenates were then ultracentrifuged (100,000g, for 40 min at 4°C), and the supernatant was removed and used as a source of the cytosolic fraction. Next, pellets were washed with 0.2 ml of Tris-HCl buffer and resuspended in 0.8 ml of buffer containing 0.3% Triton X-100 and maintained on ice for 1 h. The samples were then centrifuged (100,000g, for 1 h at 4°C), and the supernatant was used as the source of the membrane fraction. To this remaining pellet, 0.3 ml of cold (4°C) lysis buffer (150 mM NaCl, 50 mM Tris-HCl, 1 mM EDTA, 1 mM EGTA, 1% Nonidet P-40, 0.1% sodium deoxycholate, 0.1% SDS, 2 g/ml aprotinin, 2 g/ml pepstatin, 2 g/ml leupeptin, and 2 g/ml phenylmethylsulfonyl fluoride) was added. The samples were then placed on ice for 1 h and ultracentrifuged as above. The remainder of the lysate or Triton-insoluble cytoskeletal fraction was then removed. Protein content of the various cell fractions was assessed by the Bradford method (Bradford, 1976) . For total PKC extraction, which provides the fraction used to confirm total PKC-␤1 expression, scraped monolayers were placed directly into 1.5 ml of cold lysis buffer and subsequently ultracentrifuged as described above. The supernatant was used for bulk protein determination.
For immunoblotting, samples (75 g of protein/lane) were added to SDS buffer (250 mM Tris-HCl, pH 6.8, 2% glycerol, and 5% mercaptoethanol), boiled for 5 min, and then separated on 7.5% SDS-PAGE (Banan et al., 2001c) . Subsequently, proteins were transferred to nitrocellulose membranes (0.2-m pore size), and then blocked in 3% bovine serum albumin for 1 h, followed by several washes with Tris-buffered saline. The immunoblotted proteins were incubated for 2 h in Tween 20, Tris-buffered saline, 1% bovine serum albumin, and the primary mouse monoclonal anti-PKC-␤1 (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) at 1:1000 dilution for 1 h at room temperature. A horseradish peroxidase-conjugated goat anti-mouse antibody (Molecular Probes, Eugene, OR) was used as a secondary antibody at 1:3000 dilution. Proteins on membranes were visualized by enhanced chemiluminescence (Amersham Biosciences, Arlington Heights, IL) and autoradiography, and subsequently analyzed by densitometry. The identity of the PKC-␤1 band was confirmed as we previously described (Banan et al., 2001c) by using the PKC-␤1 blocking peptide (Santa Cruz Biotechnology, Inc.) in combination with the anti-PKC-␤1 antibody that prevents the appearance of the corresponding "major" band in Western blots. Additionally, in the absence of the primary antibody to PKC-␤1, no corresponding band for PKC-␤1 was observed. The PKC-␤1 band ran at the expected molecular mass of 78 kDa, as confirmed by a known positive control for PKC-␤1 (from rat brain lysates). Prestained molecular weight markers (M r 67,000 and 93,000) were run in adjacent lanes. Using total PKC extracts, we previously showed (Banan et al., 2001c ) that over-expression of PKC-␤1 or antisense inhibition of PKC-␤1 expression did not affect the relative expression levels of other PKC isoforms or injure the Caco-2 cells. 2ϩ ] i were determined using the sensitive fluorescence Ca 2ϩ -indicator Fluo-3-AM (Molecular Probes) as we described previously (Kokoska et al., 1998; Banan et al., 2001b) . Briefly, monolayers were washed two times with Hanks' balanced salt solution prior to loading with Fluo-3 for 60 min (final concentration of 4 M). Monolayers were then washed three times to remove excess Fluo-3 followed by treatment regimens. At the desired time points [Ca 2ϩ ] i was quantitated using the equation: [Ca 2ϩ 
Measurement of [Ca 2؉ ] i . Alterations in [Ca
, where F min (the minimum Fluo-3 signal) is equal to F MnCl 2 minus 0.25 F max , and K d (the dissociation constant) equals 400 nM (Vandenberghe and Ceuppens, 1990; Kokoshka et al., 1998) . The maximum Fluo-3 signal (F max ) was obtained by permeabilizing Caco-2 cells with 50 M digitonin (Sigma-Aldrich). The Fluo-3 signal was quenched to obtain F MnCl 2 using 2 mM MnCl 2 and 50 M digitonin. The heavy metal scavenger, N,N,NЈ,NЈ-tetrakis(2-pyridylmethyl)-ethylenediamine (50 M), was used in all solutions. Fluorescent signals from samples were quantitated by a fluorescence multiplate reader (FL 600; BioTek Instruments, Winooski, VT) at 37°C, employing excitation and emission wavelengths of 485 and 530 nm, respectively.
Measurement of 45 Ca 2؉ Efflux. Caco-2 cells were preloaded with 45 Ca 2ϩ (10 Ci/ml) for 1 h at 37°C and then incubated with the test agents. After centrifugation, radioactivity in the supernatant and within the lysed cells was determined by scintillation counting (Kokoska et al., 1998; Banan et al., 2001b Statistical Analysis. Data are presented as mean Ϯ S.E.M. All experiments were carried out with a sample size of at least six observations per treatment group that were run in triplicate (or in some cases in duplicate) on 2 to 3 different days. Statistical analysis comparing treatment groups was performed using analysis of variance followed by Dunnett's multiple range test (Harter, 1960) . Correlational analyses were done using the Pearson test for parametric analysis or, when applicable, the Spearman test for nonparametric analysis; p values Ͻ0.05 were deemed statistically significant.
Results
Protection of the F-Actin by EGF and PKC Activators against Oxidant-Induced Damage. Figure 1 demonstrates that preincubation of Caco-2 monolayers with EGF or PKC activators (OAG or TPA) prior to subsequent exposure to oxidant (H 2 O 2 ) dose dependently and significantly protected the F-actin against oxidant-induced disruption as measured by increases in the percentage of cells with normal actin. Since EGF (10 ng/ml), OAG (50 M), and TPA (30 nM), which we previously reported to prevent oxidant-induced disruption of the monolayer barrier and increased paracellular permeability (Banan et al., 2001b) , provided maximal protection of actin, we utilized these doses in subsequent pharmacological studies. OAG or TPA protection of actin was not significantly different from EGF-induced protection. Figure 2 shows that pretreatment with a biologically inactive phorbol ester 4␣-PDD, as expected, did not protect the actin. Preincubation with known pharmacological inhibitors of PKC (chelerythrine or GF 109203 X) prevented the protective effects of EGF or PKC activators. As expected, the inactive analog of the latter PKC inhibitor, iGF 109203 X, was not protective. PKC inhibitors by themselves did not affect Monolayers of naive cells were exposed to the shown doses of EGF or the OAG and TPA for 10 min prior to exposure to oxidant H 2 O 2 (0.5 mM) for 30 min. Cell monolayers were processed for actin staining by cellular fixation followed by incubation with fluorescein-conjugated phalloidin (specific for F-actin), and the percentage of cells displaying a normal actin was then assessed as described under Fluorescent images obtained by high-resolution laser scanning confocal microscopy from the apical cortical ring of Factin, which is known to regulate monolayer paracellular permeability (Banan et al., 2000c (Banan et al., , 2001a , corroborated the aforementioned findings on the actin (Fig. 3, a to f) . Control cells from untreated monolayers showed a normal and smooth distribution of the actin ring at the areas of cell-tocell contact (Fig. 3a) . Exposure of cell monolayers to H 2 O 2 produced extensive fragmentation, disorganization, and beading of the actin ring (Fig. 3b) . On the other hand, preincubation with EGF prevented this disruption as shown by a smooth and continuous pattern of the actin ring (Fig. 3c) . Not surprisingly, growth factor-pretreated monolayers were indistinguishable from controls (Fig. 3a) . Furthermore, PKC activators (e.g., OAG) had protective effects on the actin ring similar to that of EGF (Fig. 3e) . Moreover, preincubation with PKC inhibitors (e.g., GF 109203 X) prevented the protection of actin by EGF (Fig. 3d) or by PKC activator (Fig. 3f) .
To investigate the underlying cause of actin stability and/or instability, we performed quantitative Western immunoblotting of the polymerized F-actin pool (S2 fraction, index of actin assembly) and monomeric G-actin pool (S1 fraction, index of actin disassembly) in response to various treatment regimens (Fig. 4) . EGF and PKC activators (OAG, TPA) increased the stable F-actin fraction and decreased the unstable G-actin in monolayers exposed to oxidant, indicating stabilization of actin assembly. Oxidant alone reduced the F-actin pool while increasing the G-actin pool. Moreover, as expected, pretreatment with an inactive phorbol ester, 4␣-PDD, did not prevent actin disassembly in H 2 O 2 -exposed monolayers (37 Ϯ 1.2% for 4␣-PDD-pretreated versus 38 Ϯ 0.4% for H 2 O 2 -exposed). In additional experiments, PKC inhibitors abolished the stabilizing effects of protective agents (EGF, OAG, TPA) on the dynamics of actin assembly. For example, in monolayers incubated with H 2 O 2 , preincubation with the PKC inhibitor, GF 109203 X, inhibited most of the increase in actin assembly by EGF (41 Ϯ 0.35%), OAG (42 Ϯ 0.80%), or TPA (43 Ϯ 0.65%). As expected, the inactive analog iGF 109203 X was ineffective when preadministered before EGF (51 Ϯ 0.20%), OAG (52 Ϯ 0.70%), or TPA (54 Ϯ 0.40%) and H 2 O 2 insult. As with their effects on the percentage of normal actin, combinations of PKC inhibitors with H 2 O 2 did not potentiate H 2 O 2 -induced actin disassembly (37 Ϯ 0.6% for chelerythrine ϩ H 2 O 2 and 39 Ϯ 0.9% for GF 109203 X ϩ H 2 O 2 compared with 38 Ϯ 0.4% for H 2 O 2 alone).
A representative Western blot of actin fractions from Caco-2 monolayers (Fig. 5 ) also showed that EGF and PKC activators (e.g., OAG) increased the F-actin lane density, indicating enhanced actin polymerization (and actin stability). Once again, these protective effects on actin assembly were prevented by the PKC inhibitors (e.g., GF 109203 X) but not the inactive analog iGF 109203 X. These findings on the dynamic alterations in actin polymerization and depolymerization parallel the above-noted protective effects of EGF and PKC activators on the protection of actin ring cytoarchitecture.
We then investigated the question as to which PKC isoform is key to EGF-induced protection of the actin. Because our previous studies (Banan et al., 2001c) indicate that the ␤1 isoform of PKC is not only a major isoform of PKC in Caco-2 cells but also key to the maintenance of an intact monolayer barrier function, we explored the possible role of this isoform in the underlying mechanism of EGF protection of the integrity of the actin, including dynamic assembly of both G-and F-actin pools.
Key Role of PKC-␤1 Isoform in Protection of the F-Actin Cytoskeleton. To this end, we used novel and stably transfected intestinal cell lines we developed (Banan et al., 2001c ) that either over-or under-express PKC-␤1 compared with naive Caco-2 cells. Figure 6 and Table 1 show that over-expression (3.1-fold) of PKC-␤1-potentiated protection by EGF or PKC activators (e.g., OAG) of the F-actin against oxidant-induced injury. In cells stably over-expressing ␤1 isoform, actin integrity (as assessed by the percentage of cells displaying normal F-actin ring) was protected against oxidant damage by a low dose of EGF (1 ng/ml). This same dose of EGF did not protect the actin in naive cells. A similar synergy was seen for protection of actin by a low dose of a PKC activator (OAG, 0.01 M) (Fig. 6) . TPA caused identical effects (not shown). In all instances, the extent of protection of PKC-␤1-over-expressing cells was not significantly different from protection of naive cells by higher doses of these same agents (10 ng/ml EGF; 50 M OAG). This did not appear to be due to changes in the ability of oxidants to cause damage to actin as PKC-␤1-over-expressing cells (without EGF or OAG) and naive cells responded comparably to H 2 O 2 , both with similar and significant damage to actin (Fig. 6) . EGF or OAG alone did not affect actin compared with vehicle (percentage of normal F-actin was 99 Ϯ 1 for vehicle versus 98 Ϯ 2 for EGF or 96 Ϯ 4 for OAG). Furthermore, PKC-␤1 over-expression by itself did not protect or injure actin. As expected, transfection of only the vector (SP-72) did not protect actin against oxidant injury (e.g., percentage of normal F-actin was 98 Ϯ 2 for vector-transfected cells exposed to vehicle; 48 Ϯ 4 for vector-transfected cells exposed to H 2 O 2 alone; and 49 Ϯ 5 for vector-transfected cells incubated with 1 ng/ml EGF ϩ H 2 O 2 versus 90 Ϯ 5 for PKC-␤1 sensetransfected cells incubated with 1 ng/ml EGF ϩ H 2 O 2 ).
Multiple clones of Caco-2 cells transfected with varying amounts (1, 2, 4, and 5 g) of PKC-␤1 sense cDNA showed Representative Western immunoblot photomicrograph of the polymerized actin (S2, Triton-insoluble) extracts from naive cell monolayers following treatments. F-actin fractions were analyzed by SDS-PAGE and Western immunoblots using a monoclonal anti-actin primary antibody followed by a horseradish peroxidase-conjugated secondary antibody and then autoradiographed. The lanes from left to right correspond to: a, vehicle; b, 0.5 mM H 2 O 2 challenge; c, EGF (10 ng/ml) ϩ 0.5 mM H 2 O 2 ; d, PKC inhibitor (GF 109203 X) ϩ EGF (10 ng/ml) ϩ 0.5 mM H 2 O 2 ; e, inactive analog of PKC inhibitor (iGF 109203 X) ϩ EGF (10 ng/ml) ϩ 0.5 mM H 2 O 2 ; f, OAG (50 M) ϩ 0.5 mM H 2 O 2 ; g, PKC inhibitor (GF 109203 X) ϩ OAG (50 M) ϩ 0.5 mM H 2 O 2 ; h, inactive PKC inhibitor (iGF 109203 X) ϩ OAG (50 M) ϩ 0.5 mM H 2 O 2 ; i, actin standard (43 kDa).
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at ASPET Journals on October 25, 2017 jpet.aspetjournals.org (Table 1) dose-dependent synergistic protection of the actin. Because the clone transfected with 4 g of PKC-␤1 sense DNA provided almost complete (90%) protection of actin ( Fig.  6 and Table 1), we used this clone in all subsequent experiments. In terms of the responses of these various transfected clones to H 2 O 2 exposure (alone), we did not observe any significant differences from one clone to the next clone (1 to 5 g) or even when compared with the naive cells that were exposed to the same oxidant (4 g clone shown in Fig. 6 ). Thus, an average (mean Ϯ S.E.M.) of these groups is presented as H 2 O 2 alone in Table 1 .
High-resolution fluorescent images obtained by laser scanning confocal microscopy from the apical cortical ring of Factin corroborated the above findings. Figure 7 shows that over-expression of PKC-␤1 potentiates protection by low doses of EGF (Fig. 7e) or OAG (Fig. 7f) . This synergy is shown by the appearance of normal, intact, and smooth architecture of the actin ring at the areas of cell-to-cell contact (Fig. 7 , e and f). The appearance of the actin ring in these transfected cells was indistinguishable from the untreated normal cells, which also showed an intact pattern of the actin ring (Fig.  7a) . Without the synergy afforded by PKC-␤1 over-expression, naive cells pretreated with the same low doses of EGF and OAG and exposed to H 2 O 2 showed extensive disorganization, condensation, and beading of the actin ring at areas associated with the plasma membrane (Fig. 7, c and d , respectively) as did naive cells exposed to H 2 O 2 alone (Fig. 7b) .
Immunoblotting analysis of the F-actin fraction (S2, an index of actin integrity) and the G-actin fraction (S1, an index of actin disruption) (Fig. 8A) further demonstrates that only the transfected cells over-expressing PKC-␤1 exhibit a synergy between low doses of EGF (1 ng/ml) or OAG (0.01 M) and PKC-␤1 as indicated by normal dynamics of actin polymerization. Transfected cells exposed to low doses of EGF or OAG and then H 2 O 2 had enhanced levels of the polymerized F-actin and reduced levels of monomeric G-actin; this was comparable with the normal controls. In contrast, H 2 O 2 alone reduced polymerized F-actin and increased monomeric Gactin in both naive cells and PKC-␤1-over-expressing cells (without added EGF or OAG), indicating disruption of actin. Pretreatment of naive cells with only the higher doses of EGF (10 ng/ml) or OAG (50 M) resulted in normal steady-state levels of actin polymerization. Similar to the above-noted effects on actin architecture, transfection of vector alone was not effective in protecting or maintaining normal pools of actin (not shown). A novel sense-transfected cell line previously developed in our laboratory (see Materials and Methods) that over-expresses PKC-␤1 by 3.1-fold was utilized. Transfected "(T)" cells stably over-expressing PKC-␤1 were incubated in low doses of EGF (1 ng/ml) or the PKC activator OAG (0.01 M) prior to the subsequent exposure to oxidant H 2 O 2 (0.5 mM). These low doses do not protect F-actin against oxidant injury in naive "(N)" cells, but they do protect F-actin in transfected cells over-expressing PKC-␤1. Only high doses of EGF (10 ng/ml) or OAG (50 M) protected actin in naive monolayers (not over-expressing ␤1). Also note synergy-induced protection of the actin in PKC-␤1-over-expressing (T) cells that were exposed to low doses of EGF or OAG. In the absence of these low doses of EGF or OAG, both PKC-␤1-over-expressing cells and naive cells responded comparably to oxidant insult to actin, both displaying significant reduction in the percentage of cells with normal actin. A representative immunoblot of the polymerized actin fraction from Caco-2 monolayers is shown in Fig. 8B . It demonstrates, once again, that PKC-␤1 over-expression synergizes with low doses of EGF or OAG to increase the F-actin lane (band) density, indicating enhancement of actin assembly and stability. These various findings on dynamic alterations in actin polymerization and depolymerization parallel the synergistic effects of PKC-␤1 over-expression on the protection of actin ring architecture.
Activation of Over-Expressed PKC-␤1 Correlates with Three Different Indices of Actin Integrity. We initially confirmed our recent findings (Banan et al., 2001b,c) in both naive and transfected, PKC-␤1-over-expressing intestinal cells that EGF or PKC activators translocate the ␤1 (ϳ78 kDa) isoform of PKC from the cytosol to both membrane-and cytoskeletal-bound fractions. In particular, following pretreatment with low doses of EGF or OAG, there is a rapid redistribution of over-expressed PKC-␤1 isoform from a mostly cytosolic distribution into particulate fractions (i.e., particulate ϭ membrane ϩ cytoskeletal fractions), indicating the induced activation of the ␤1 isoform (Fig. 9A ). This figure also shows a temporal relationship between PKC-␤1 (optical PKC-␤1-over-expressing cell monolayers (panels e and f) were also exposed to the same low doses of EGF (panel e) or OAG (panel f) and then incubated with the same H 2 O 2 concentration. Normal cells (panel a) reveal an intact and smooth architecture of apical actin cortex (i.e., ring) on the inner side of the plasma membrane (areas of cell-to-cell contact), whereas cells exposed to H 2 O 2 (panel b) show fragmentation, beading, and disruption of the actin ring. Cells over-expressing PKC-␤1, which were exposed to low doses of EGF (panel e) or OAG (panel f) before oxidant exposure, exhibit a highly preserved appearance of the apical actin ring, which is indistinguishable from the normal cells (panel a). In contrast, this protection did not occur in naive cells (not over-expressing PKC-␤1; panels c and d) that were pre-exposed to these same low doses of EGF (panel c) or OAG (panel d), as shown by the abnormal cytoarchitecture of the actin ring. . In transfected cells the over-expressed PKC-␤1 in the presence of a low dose of EGF (1 ng/ml) or OAG (0.01 M) increases the polymerized F-actin band density to almost normal levels. In naive cells, on the other hand, preincubation with these same low doses of EGF or OAG does not increase actin polymerization, which is similar to that of the oxidant-exposed groups. Also shown are high concentrations of EGF (10 ng/ml) or OAG (50 M), which are the only doses that increase actin assembly in naive cells.
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at ASPET Journals on October 25, 2017 jpet.aspetjournals.org density from the particulate fraction) and actin ring integrity. When these two variables were plotted against each other, we found a robust correlation (r ϭ 0.93, p Ͻ 0.05). When two other markers of actin stability, F-actin polymerization and G-actin disassembly, were plotted against PKC-␤1 (Fig. 9 , B and C), additional robust correlations were observed (r ϭ 0.92 and 0.91, respectively, p Ͻ 0.05 for each), further suggesting that increased activation of ␤1 isoform is key in protection of actin integrity.
Stable Antisense Inhibition of PKC-␤1 and Its Inhibition of EGF-Induced Protection of Actin.
To further investigate a possible role for PKC-␤1 in EGFmediated protection of actin, we utilized Caco-2 cells that were transfected with PKC-␤1 antisense plasmid and cDNA encoding G-418 resistance. We confirmed our earlier reports (Banan et al., 2001c ) that this manipulation substantially (ϳ90%) and stably reduces the steady-state levels of PKC-␤1 protein.
Analysis of the percentage of cells with a normal actin indicates that antisense inhibition of PKC-␤1 expression substantially inhibited the protection of actin by high doses of EGF (10 ng/ml) or PKC activator (OAG, 50 M) (Fig. 10 and Table 1 ), doses that almost completely protected actin in naive cells against exposure to oxidant. Under-expression of the PKC-␤1 isoform by itself did not damage actin. Table 1 also shows the effects of varying amounts of ␤1 antisense cDNA (1, 4, and 5 g) on the attenuation of EGF or OAGmediated protection of actin. Similar to our over-expression (sense) studies, the antisense data also indicate a dose-dependent phenomenon. The clone transfected with 4 g of ␤1 antisense cDNA led to maximum inhibition of EGF-or OAGinduced protection of actin. Accordingly, this antisense clone was used in all subsequent inhibition experiments. Quantitative immunoblotting analysis of the actin fractions from antisense transfected cells further demonstrates (Fig. 11) that stable under-expression of PKC-␤1 isoform prevented EGF-or OAG-induced enhancement of the stable F-actin pool and the reduction of the monomeric G-actin pool. 2؉ ] i in PKC-␤1 Transfected Cells. Because our previous studies showed that EGF normalizes [Ca 2ϩ ] i in the face of oxidant challenge, we surmised that normalization of [Ca 2ϩ ] i might be a key mechanism for PKC-␤1-induced, EGF-mediated protection. Indeed, measurement of [Ca 2ϩ ] i in monolayers prelabeled with the Ca 2ϩ -sensitive dye Fluo-3 (Fig. 12A) showed that PKC-␤1 over-expression synergized with low doses of EGF (1 ng/ml) or OAG (0.01 M) to maintain [Ca 2ϩ ] i at almost control levels. These same low doses of EGF or OAG did not normalize [Ca 2ϩ ] i in naive cells. Additionally, the extent of normalization of [Ca 2ϩ ] i in transfected cells exposed to these low doses was not significantly different from the extent of normalization of [Ca 2ϩ ] i in naive cells by higher doses of EGF or OAG (Fig. 12A) . This did not appear to be due to changes in the ability of oxidants to markedly increase [Ca 2ϩ ] i since PKC-␤1-over-expressing cells (without EGF or OAG) and naive cells responded similarly to H 2 O 2 , both with comparable and significant increases in [Ca 2ϩ ] i . For example, naive monolayers exposed to H 2 O 2 exhibited [Ca 2ϩ ] i levels at 327 Ϯ 10 nM compared with 122 Ϯ 7 nM for vehicle. Furthermore, transfection of vector alone was ineffective ([Ca 2ϩ ] i ϭ 125 Ϯ 10 nM for vector-transfected cells exposed to vehicle, 321 Ϯ 9 nM for vector-transfected cells exposed to H 2 O 2 , and 324 Ϯ 15 nM for vector-transfected cells incubated with 1 ng/ml EGF ϩ H 2 O 2 versus 138 Ϯ 15 nM for PKC-␤1 sense-transfected cells incubated with 1 ng/ml EGF ϩ H 2 O 2 ). Figure 12B shows that preincubation with two different inhibitors of the membrane Ca 2ϩ -ATPase pump, quercetine or vanadate, abrogated the synergy-induced normalization of [Ca 2ϩ ] i in PKC-␤1-over-expressing cells exposed to low doses of EGF or OAG, as [Ca 2ϩ ] i levels remained elevated. These Ca 2ϩ -ATPase inhibitors by themselves had no significant effects on baseline Ca 2ϩ levels. To further investigate the possibility that PKC-␤1 plays a key role in the normalization of [Ca 2ϩ ] i by EGF, stable antisense inhibition of this PKC isoform was utilized. Figure 13 shows that under-expression of PKC-␤1 inhibited the normalization of [Ca 2ϩ ] i at high levels, we hypothesized that Ca 2ϩ efflux is an essential mechanism for PKC-␤1-induced (EGF) normalization of [Ca 2ϩ ] i . Indeed, assessment of Ca 2ϩ efflux from monolayers prelabeled with 45 Ca 2ϩ (Fig. 14A) showed that PKC-␤1 overexpression synergized with the low doses of EGF (1 ng/ml) or OAG (0.01 M) to markedly and significantly enhance Ca 2ϩ efflux. These same doses were ineffective in naive cells; only high doses were effective. Furthermore, two different inhibitors of the membrane Ca 2ϩ -ATPase pump (Fig. 14B) , quercetine and vanadate, abolished this enhancement in Ca 2ϩ efflux. We did not observe any significant changes in Ca 2ϩ efflux in vector (SP-72)-alone transfected cell monolayers (Ca 2ϩ efflux ϭ 51 Ϯ 4% for vectortransfected cells exposed to vehicle, 43 Ϯ 2% for vectortransfected cells exposed to H 2 O 2 , and 49 Ϯ 5% for vectortransfected cells incubated with 1 ng/ml EGF ϩ H 2 O 2 versus 84 Ϯ 3% for PKC-␤1 sense-transfected incubated with 1 ng/ml EGF ϩ H 2 O 2 ). These data on efflux parallel our data on [Ca 2ϩ ] i . Finally, we observed (Fig. 15) that the antisense inhibition of PKC-␤1 expression prevents the increases in Ca 2ϩ efflux induced by high (protective) doses of EGF or PKC activator.
Normalization of [Ca 2؉ ] i Concentration: Prevention of Oxidant-Induced Rise in [Ca
Antisense inhibition by itself did not affect baseline Ca 2ϩ efflux.
Discussion
In the current study, we demonstrate that activation of the ␤1 isoform of PKC is required for EGF-mediated protection of the cortical F-actin cytoskeletal assembly and cytoarchitecture in intestinal cells. It is also required for EGF-induced normalization of Ca 2ϩ homeostasis against oxidant-induced injury in enterocytes. The PKC-␤1 isoform also appears to be a critical stabilizer of the dynamic alterations in polymerized (F-) actin and monomeric (G-) actin cytoskeletons in the intestinal epithelium. To our knowledge, this is the first demonstration of this novel mechanism for the protection of Ca 2ϩ balance and actin integrity in GI cells. The following independent lines of evidence support and elaborate on these conclusions.
First, preincubation of naive intestinal monolayers with high doses of EGF activates PKC-␤1 and evokes a cascade of alterations that are consistent with the proposed mechanism. EGF activates a specific PKC isoform, ␤1, increases Ca 2ϩ efflux, normalizes cytosolic Ca 2ϩ , increases the size of the polymerized F-actin pool while reducing the size of the mo- nomeric G-actin pool, and increases the number of cells displaying a normal actin ring at the apical plane of monolayers (an area known to regulate intestinal paracellular permeation; Banan et al., 2000c Banan et al., , 2001a .
Second, these protective effects of EGF on the actin are mimicked by known PKC activators but not by a biologically inactive phorbol ester. Third, the protective effects of EGF or PKC activators on the actin are prevented by specific PKC inhibitors. Fourth, transfected cells that over-express PKC-␤1 are severalfold more sensitive to protection of the F-actin ring structure by EGF or the PKC activator OAG. Indeed, in these stably transfected cells, PKC-␤1 over-expression synergized with the exogenously added EGF or OAG to increase the stability of F-actin, to decrease the unstable G-actin, to protect a high percentage of cells with normalappearing cortical actin ring, and to maintain cytosolic Ca 2ϩ at nearly normal levels via increases in Ca 2ϩ efflux. The enhanced sensitivity to EGF in transfected Caco-2 cells appears to require not only over-expression, which is not protective by itself, but also enhanced activation of PKC-␤1. Fifth, antisense to PKC-␤1, which causes under-expression of PKC-␤1 at only 10% of normal levels, almost completely abrogated all the various protective effects of EGF and PKC activator.
Finally, quantitative considerations such as correlations between several outcome measures further support our conclusions. Our previous work in naive intestinal cells showed significant correlations between protection of the integrity of monolayer barrier permeability and actin ring stability (Banan et al., 2000c (Banan et al., , 2001a and between the integrity of the intestinal barrier and enhanced general PKC activation (Banan et al., 2001b ). In the current study, we show correlations between protection against actin ring disruption and increased PKC-␤1 isoform activation (i.e., membrane association) (r ϭ 0.93, p Ͻ 0.05) as well as between protection against actin disassembly (increase in G-actin) and enhanced PKC-␤1 activation (r ϭ 0.91, p Ͻ 0.05), and between protection of actin assembly (increase in F-actin) and PKC-␤1 activation (r ϭ 0.92, p Ͻ 0.05).
In our previous investigations using the same transfected and naive monolayer models (e.g., Banan et al., 2000a Banan et al., ,c, 2001a Banan et al., ,c, 2002 , we utilized several membrane-impermeable fluorescent probes such as fluorescein sulfonic acid (FSA; 0.478 kDa) for assessing intestinal barrier permeability (leakiness). Our findings showed that first there is a paracellular permeation of permeability probes in Caco-2 monolayers following exposure to oxidants. Second, there is an inverse relationship between the probe size and leakiness. Third, PKC-␤1 activation prevents the passage of these small permeability probes (e.g., FSA) through the paracellular route, indicating protection/maintenance of monolayer barrier integrity. We also showed significant correlations between protection of the integrity of the monolayer barrier (FSA clearance) and actin ring stability (Banan et al., 2000c (Banan et al., , 2001a and between the integrity of the intestinal barrier and general PKC activity (Banan et al., 2001b,c) , and now in the present study between protection of the actin ring and increased ␤1 isoform activation.
Our present and previous findings are consistent with a model in which enhanced translocation and activation of PKC-␤1 results in increased polymerization of F-actin and concomitant reduction in G-actin pools and subsequently leads to increased stability of the actin architecture and the monolayer barrier. Furthermore, protection against oxidantinduced rise in [Ca 2ϩ ] i and increased PKC-␤1 activation (r ϭ 0.91, p Ͻ 0.05) and increase in Ca 2ϩ efflux and enhanced PKC-␤1 activation (r ϭ 0.89, p Ͻ 0.05) provide other robust correlations in the current report. The high strength of these correlations indicates that increased PKC-␤1 activation is apparently essential to the protective effects of EGF (and the PKC activator OAG) on calcium balance and actin. In this view, enhanced activation of PKC-␤1 leads to the normalization of [Ca 2ϩ ] i and the protection of F-actin. Other PKC isoforms also appear to be protective, as we have recently discovered (Banan et al., 2002) , and these other isoforms may modulate additional signaling mechanisms.
Our findings using targeted molecular interventions are consistent with previous pharmacological reports (Boner et al., 1992; Saxon et al., 1994; McKenna et al., 1995; Birkenfeld et al., 1996; Wang et al., 1996) , including our own (Banan et al., 2001b) , in which general PKC activation (translocation) was shown to be necessary for the observed effects of PKC. An immunofluorescent study in non-GI cells such as fibroblasts showed that OAG (a synthetic version of diacylglycerol) causes the activation of a constitutively expressed PKC-␤1 isoform (Goodnight et al., 1995) . Our current findings on the ␤1 isoform of PKC utilizing more specific and targeted molecular approaches further expand on these previous pharmacological reports and, we believe, now establish a novel biologic function-protection of Ca 2ϩ balance and actin-among the classical isoforms of PKC. Furthermore, we have more recently identified activation of EGF-receptor tyrosine kinase and then phospholipase C-␥1 as the upstream signal for EGF-induced, PKC-mediated, protection of intestinal barrier and cytoskeletal integrity (Banan et al., 2001d) .
Despite the fundamental importance of PKC signal transduction in protection as our previous and current studies indicate, the role of the PKC-␤1 isoform in cell function, especially in epithelial cells, has remained poorly understood. Although PKC in general has been implicated in reorganization of the cytoskeleton (Hartwig et al., 1992; Goodnight et al., 1995; Babich et al., 1997; Chun et al., 1997; He et al., 1997) , it is not known which PKC isoforms are important in this process. Our study indicates that PKC-␤1 is one such isoform. The mechanism through which PKC-␤1 isoform protects the actin is unclear. Studies in chromaffin cells suggest that one possible target of PKC might be MARCKS (myristoylated, alanine-rich PKC substrate), which has been proposed to rearrange the actin cytoskeleton (Hartwig et al., 1992) . Moreover, PKC has been suggested to be a MARCKS kinase. Alternatively, PKC-␤1 may directly phosphorylate the actin molecule itself, leading to dynamic redistribution of actin cortex. It should be noted that other proteins can also be involved in maintaining the integrity of an epithelial barrier in the GI tract, including microtubules (Banan et al., 1999 (Banan et al., , 2000a , E-cadherin, adherin, connexin 43, ␤-catenin, EGFreceptor, and integrins, and some of these proteins (e.g., microtubules) are also phosphorylated by PKC, including PKC-␤1 (e.g., Banan et al., 2001c) . It remains to be seen whether there are additional molecular mechanisms underlying the interactions between PKC-␤1 and F-actin in GI epithelial cells.
Utilizing a pharmacological approach, we previously showed in naive intestinal cells that known PKC activators (e.g., OAG) attenuate oxidant-induced increases in cytosolic Ca 2ϩ through stimulation of Ca 2ϩ efflux, leading to the normalization of intracellular Ca 2ϩ (Banan et al., 2001b) . The nature of the PKC isoform responsible for this protective phenomenon remained elusive until the current report. The effects of the ␤1 isoform of PKC on cellular Ca 2ϩ trafficking as reported herein are potentially important because we and others have shown that the cytoskeleton is exquisitely sensitive to changes in intracellular Ca 2ϩ levels and that it can be extensively injured by oxidantinduced increases in intracellular Ca 2ϩ , leading to monolayer barrier hyperpermeability (Kakiuchi and Sobue, 1981; Babich et al., 1997; Banan et al., 2001b) . Our studies using Ca 2ϩ -ATPase pump inhibitors show the inhibition of efflux, which is then responsible for the return of [Ca 2ϩ ] i to normal levels. For example, direct phosphorylation of the Ca 2ϩ -ATPase via the pharmacological manipulation of PKC was suggested by two recent studies in non-GI (nonepithelial) cells such as HL-60 leukemia cells and neutrophils (Enyedi et al., 1997; Verma et al., 1999) . Consistent with our current report in epithelial cells, in neutrophils and in HL-60 cells, ligand-initiated (e.g., fMLP) signaling elicits a PKC-induced down-regulation of the rise in [Ca 2ϩ ] i (Enyedi et al., 1997; Verma et al., 1999) . Studies are under way in our laboratory to determine to what extent PKC isoform-activated protection of calcium balance is mediated by effects on membrane Ca 2ϩ -ATPases. In summary, our findings demonstrate for the first time that the ability of growth factors to protect the actin cytoskeleton and maintain normal intracellular calcium homeostasis in intestinal cell monolayers is substantially dependent on increased activation of the PKC-␤1 isoform. This new knowledge may prove useful because increasing the activity of protective PKC isoforms through activation of endogenous PKC or using PKC mimetics may lead to unique therapeutic strategies for the treatment of a wide variety of oxidantinduced inflammatory disorders of the GI tract, including inflammatory bowel disease. 
